Overview Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus Status: Unknown status Trial end date: 2020-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the efficacy and safety of DWP16001 compared to placebo in the treatment of type 2 diabetes mellitus. Phase: Phase 2 Details Lead Sponsor: Daewoong Pharmaceutical Co. LTD.